ASCO GI 2026, the American Society of Clinical Oncology Gastrointestinal Cancers Symposium, is a premier international conference. It highlights the latest...
The American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium is an annual meeting dedicated to presenting the latest research and clinical advances in the prevention, diagnosis, and treatment of cancers affecting the digestive system.
The symposium focuses on all gastrointestinal malignancies, including esophageal, gastric, colorectal, pancreatic, liver, and biliary tract cancers, among others.
Attendees include oncologists, gastroenterologists, surgeons, radiation oncologists, researchers, nurses, and other healthcare professionals involved in the care of patients with GI cancers, as well as industry representatives.
It serves as a critical platform for disseminating groundbreaking research, discussing emerging therapies, and sharing best practices in gastrointestinal oncology, ultimately shaping future clinical care and improving patient outcomes worldwide.
Specific dates and location for ASCO GI 2026 are typically announced closer to the event (e.g., late 2024 or early 2025). Historically, the symposium takes place in January in major US cities like San Francisco or Orlando.